|
18 Jan 2011 |
EHSI Forms Joint Venture to Develop Stem-Cell Treatment for Liver Disease
|
|
18 Jan 2011 |
Mirna Therapeutics and Collaborators Publish New Data on miR-34 and its Role in Cancer Stem Cells
|
|
18 Jan 2011 |
Oncolytics Biotech Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study
|
|
18 Jan 2011 |
Pluristem on Track to Proceed to a Phase II/III Clinical Trial in Critical Limb Ischemia (CLI) Under a Joint FDA-EMA Protocol, and a Phase II Clinical Trial in Intermittent Claudication (IC)
|
|
17 Jan 2011 |
Diamyd Medical: Diamyd Starts Phase II Study in Cancer Pain
|
|
14 Jan 2011 |
Health Canada Requests Additional Information to Support Application for Approval of Prochymal
|
|
12 Jan 2011 |
VistaGen Therapeutics and NuPotential Receive NIH Grant to Develop Safer Approaches for Producing Patient-Specific Induced Pluripotent Stem Cells
|
|
12 Jan 2011 |
Fibrocell Science, Inc. Announces FDA Accepts for Review Complete Response Submission for Azficel-T
|
|
10 Jan 2011 |
Geron Announces Publication Demonstrating Activity of Imetelstat Against Cancer Stem Cells From Pediatric Neural Tumors
|
